The Synthetic Immunomodulator Murabutide Controls Human Immunodeficiency Virus Type 1 Replication at Multiple Levels in Macrophages and Dendritic Cells

Ítems similars

• Interleukin-16 Inhibits Human Immunodeficiency Virus Type 1 Entry and Replication in Macrophages and in Dendritic Cells
  per: Truong, Marie-Jose, et al.
  Publicat: (1999)
• Selective Regulation of Human Immunodeficiency Virus-Infected CD4(+) Lymphocytes by a Synthetic Immunomodulator Leads to Potent Virus Suppression In Vitro and in hu-PBL-SCID Mice
  per: Bahr, George M., et al.
  Publicat: (2001)
• Enhanced maturation and functional capacity of monocyte-derived immature dendritic cells by the synthetic immunomodulator Murabutide
  per: Vidal, Vincent, et al.
  Publicat: (2001)
• The transcriptional response of human macrophages to murabutide reflects a spectrum of biological effects for the synthetic immunomodulator
  per: GOASDUFF, T, et al.
  Publicat: (2002)
• Nonneutralizing Antibodies Are Able To Inhibit Human Immunodeficiency Virus Type 1 Replication in Macrophages and Immature Dendritic Cells
  per: Holl, Vincent, et al.
  Publicat: (2006)